Effect of a palliative home care team on hospital admissions among patients with advanced cancer

Massimo Costantini, Irene J. Higginson, Luca Boni, Maria Antonietta Orengo, Elsa Garrone, Franco Henriquet, Paolo Bruzzi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

This was a quasi-experimental study designed to determine whether, in patients with advanced cancer, a palliative home care team (PHCT) modified hospital utilization in the last six months before death. Of 2503 cancer deaths in the municipality of Genoa, Italy, in 1991, 189 (7.5%) received care from a PHCT. Three hundred and seventy-eight controls matched for primary tumour were selected. The groups were similar in terms of age, gender and most other demographic variables, except that educational level was lower, and times to death, from first diagnosis and from diagnosis of advanced or metastatic cancer, were longer among PHCT patients compared with the controls. Before referral to a PHCT, or a matched time in controls, both groups spent about 15% of days in hospital. After admission to a PHCT, the percentages of days in hospital increased in both groups as death approached, but it was much higher in the control group (30.3%; 95% confidence interval (CI): 26-34) than in the PHCT group (19.0%; 95% CI: 15-23). The difference between groups was most marked in the last month of life, and disappeared among those patients who were in care for more than 120 days (throughout the course of their illness). We conclude that a PHCT appears to reduce days in hospital and allows patients to spend more time at home. Differences in time in care between groups requires further investigations.

Original languageEnglish
Pages (from-to)315-321
Number of pages7
JournalPalliative Medicine
Volume17
Issue number4
DOIs
Publication statusPublished - 2003

Fingerprint

Patient Admission
Home Care Services
Palliative Care
Neoplasms
Confidence Intervals
Control Groups
Italy
Referral and Consultation
Demography

Keywords

  • Cancer
  • Effectiveness
  • Evaluation
  • Home care
  • Palliative care

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)

Cite this

Effect of a palliative home care team on hospital admissions among patients with advanced cancer. / Costantini, Massimo; Higginson, Irene J.; Boni, Luca; Orengo, Maria Antonietta; Garrone, Elsa; Henriquet, Franco; Bruzzi, Paolo.

In: Palliative Medicine, Vol. 17, No. 4, 2003, p. 315-321.

Research output: Contribution to journalArticle

Costantini, Massimo ; Higginson, Irene J. ; Boni, Luca ; Orengo, Maria Antonietta ; Garrone, Elsa ; Henriquet, Franco ; Bruzzi, Paolo. / Effect of a palliative home care team on hospital admissions among patients with advanced cancer. In: Palliative Medicine. 2003 ; Vol. 17, No. 4. pp. 315-321.
@article{7aa100a4b332438eb35063eaee3803f5,
title = "Effect of a palliative home care team on hospital admissions among patients with advanced cancer",
abstract = "This was a quasi-experimental study designed to determine whether, in patients with advanced cancer, a palliative home care team (PHCT) modified hospital utilization in the last six months before death. Of 2503 cancer deaths in the municipality of Genoa, Italy, in 1991, 189 (7.5{\%}) received care from a PHCT. Three hundred and seventy-eight controls matched for primary tumour were selected. The groups were similar in terms of age, gender and most other demographic variables, except that educational level was lower, and times to death, from first diagnosis and from diagnosis of advanced or metastatic cancer, were longer among PHCT patients compared with the controls. Before referral to a PHCT, or a matched time in controls, both groups spent about 15{\%} of days in hospital. After admission to a PHCT, the percentages of days in hospital increased in both groups as death approached, but it was much higher in the control group (30.3{\%}; 95{\%} confidence interval (CI): 26-34) than in the PHCT group (19.0{\%}; 95{\%} CI: 15-23). The difference between groups was most marked in the last month of life, and disappeared among those patients who were in care for more than 120 days (throughout the course of their illness). We conclude that a PHCT appears to reduce days in hospital and allows patients to spend more time at home. Differences in time in care between groups requires further investigations.",
keywords = "Cancer, Effectiveness, Evaluation, Home care, Palliative care",
author = "Massimo Costantini and Higginson, {Irene J.} and Luca Boni and Orengo, {Maria Antonietta} and Elsa Garrone and Franco Henriquet and Paolo Bruzzi",
year = "2003",
doi = "10.1191/0269216303pm744oa",
language = "English",
volume = "17",
pages = "315--321",
journal = "Palliative Medicine",
issn = "0269-2163",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Effect of a palliative home care team on hospital admissions among patients with advanced cancer

AU - Costantini, Massimo

AU - Higginson, Irene J.

AU - Boni, Luca

AU - Orengo, Maria Antonietta

AU - Garrone, Elsa

AU - Henriquet, Franco

AU - Bruzzi, Paolo

PY - 2003

Y1 - 2003

N2 - This was a quasi-experimental study designed to determine whether, in patients with advanced cancer, a palliative home care team (PHCT) modified hospital utilization in the last six months before death. Of 2503 cancer deaths in the municipality of Genoa, Italy, in 1991, 189 (7.5%) received care from a PHCT. Three hundred and seventy-eight controls matched for primary tumour were selected. The groups were similar in terms of age, gender and most other demographic variables, except that educational level was lower, and times to death, from first diagnosis and from diagnosis of advanced or metastatic cancer, were longer among PHCT patients compared with the controls. Before referral to a PHCT, or a matched time in controls, both groups spent about 15% of days in hospital. After admission to a PHCT, the percentages of days in hospital increased in both groups as death approached, but it was much higher in the control group (30.3%; 95% confidence interval (CI): 26-34) than in the PHCT group (19.0%; 95% CI: 15-23). The difference between groups was most marked in the last month of life, and disappeared among those patients who were in care for more than 120 days (throughout the course of their illness). We conclude that a PHCT appears to reduce days in hospital and allows patients to spend more time at home. Differences in time in care between groups requires further investigations.

AB - This was a quasi-experimental study designed to determine whether, in patients with advanced cancer, a palliative home care team (PHCT) modified hospital utilization in the last six months before death. Of 2503 cancer deaths in the municipality of Genoa, Italy, in 1991, 189 (7.5%) received care from a PHCT. Three hundred and seventy-eight controls matched for primary tumour were selected. The groups were similar in terms of age, gender and most other demographic variables, except that educational level was lower, and times to death, from first diagnosis and from diagnosis of advanced or metastatic cancer, were longer among PHCT patients compared with the controls. Before referral to a PHCT, or a matched time in controls, both groups spent about 15% of days in hospital. After admission to a PHCT, the percentages of days in hospital increased in both groups as death approached, but it was much higher in the control group (30.3%; 95% confidence interval (CI): 26-34) than in the PHCT group (19.0%; 95% CI: 15-23). The difference between groups was most marked in the last month of life, and disappeared among those patients who were in care for more than 120 days (throughout the course of their illness). We conclude that a PHCT appears to reduce days in hospital and allows patients to spend more time at home. Differences in time in care between groups requires further investigations.

KW - Cancer

KW - Effectiveness

KW - Evaluation

KW - Home care

KW - Palliative care

UR - http://www.scopus.com/inward/record.url?scp=0038001583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038001583&partnerID=8YFLogxK

U2 - 10.1191/0269216303pm744oa

DO - 10.1191/0269216303pm744oa

M3 - Article

VL - 17

SP - 315

EP - 321

JO - Palliative Medicine

JF - Palliative Medicine

SN - 0269-2163

IS - 4

ER -